FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
Info on ICH Benefit/Risk Report Sent to OMB
05/09/2014
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
Court Backs FDA Lumryz Approval
FDA: Compounders Should Use Suitable Ingredients
UCBs Bepranemab Misses Primary Endpoint
FDA Extends Some Baxter Parenteral Drug Product Use Dates
Warning on Skin-Cap Spray Products
Use Risk-Based AI/ML Regulation: AstraZeneca
Datex-Ohmeda Recalls Giraffe OmniBeds
Verastem Oncology NDA for Rare Ovarian Cancer
LATEST NEWS
Read More
Human Drugs
Court Backs FDA Lumryz Approval
Read More
Human Drugs
FDA: Compounders Should Use Suitable Ingredients
Read More
Human Drugs
UCBs Bepranemab Misses Primary Endpoint
Read More
Human Drugs
FDA Extends Some Baxter Parenteral Drug Product Use Dates
FDA Webview Free Daily e-Newsletter
Free Sign-Up
